TR201007508A1 - Oral yolla dağılan bileşimler - Google Patents

Oral yolla dağılan bileşimler

Info

Publication number
TR201007508A1
TR201007508A1 TR2010/07508A TR201007508A TR201007508A1 TR 201007508 A1 TR201007508 A1 TR 201007508A1 TR 2010/07508 A TR2010/07508 A TR 2010/07508A TR 201007508 A TR201007508 A TR 201007508A TR 201007508 A1 TR201007508 A1 TR 201007508A1
Authority
TR
Turkey
Prior art keywords
orally dispersible
dispersible compositions
compound
pharmaceutically acceptable
orally
Prior art date
Application number
TR2010/07508A
Other languages
English (en)
Inventor
Ümi̇t Çi̇fter Musa
Türkyilmaz Ali̇
Mutlu Onur
Ramazanoğlu Gaye
Original Assignee
Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San. Ve Ti̇c. A.Ş. filed Critical Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority to TR2010/07508A priority Critical patent/TR201007508A1/tr
Priority to PL11181153T priority patent/PL2428202T3/pl
Priority to EP11181153.5A priority patent/EP2428202B1/en
Priority to ES11181153.5T priority patent/ES2547138T3/es
Publication of TR201007508A1 publication Critical patent/TR201007508A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş. Formül I Bileşiğim (Bileşik I) ya da onun farmasotik olarak kabul edilebilir tuzlannı ve bir ya da birden fazla farmasotik olarak kabul edilebilir yardımcı madde içeren bir oral yolla dağılan bileşimle ilgilidir
TR2010/07508A 2010-09-14 2010-09-14 Oral yolla dağılan bileşimler TR201007508A1 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2010/07508A TR201007508A1 (tr) 2010-09-14 2010-09-14 Oral yolla dağılan bileşimler
PL11181153T PL2428202T3 (pl) 2010-09-14 2011-09-13 Kompozycje ulegające rozpadowi w jamie ustnej
EP11181153.5A EP2428202B1 (en) 2010-09-14 2011-09-13 Orally disintegrating compositions
ES11181153.5T ES2547138T3 (es) 2010-09-14 2011-09-13 Composiciones que se disgregan por vía oral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07508A TR201007508A1 (tr) 2010-09-14 2010-09-14 Oral yolla dağılan bileşimler

Publications (1)

Publication Number Publication Date
TR201007508A1 true TR201007508A1 (tr) 2012-04-24

Family

ID=43972063

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/07508A TR201007508A1 (tr) 2010-09-14 2010-09-14 Oral yolla dağılan bileşimler

Country Status (4)

Country Link
EP (1) EP2428202B1 (tr)
ES (1) ES2547138T3 (tr)
PL (1) PL2428202T3 (tr)
TR (1) TR201007508A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7322474B2 (ja) * 2019-04-04 2023-08-08 ニプロ株式会社 アジルサルタンを含有する錠剤
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053798A1 (en) * 1997-05-27 1998-12-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation
WO1999025321A1 (en) * 1997-11-17 1999-05-27 Smithkline Beecham Corporation High drug load immediate and modified release oral dosage formulations and processes for their manufacture
DE102006027794A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertonie-Kombinationswafer
GB2460915A (en) * 2008-06-16 2009-12-23 Biovascular Inc Controlled release compositions for use in reducing circulating levels of platelets
WO2010075347A2 (en) * 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201004754A1 (tr) * 2010-06-11 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Yeni Farmasötik Kombinasyonlar

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053798A1 (en) * 1997-05-27 1998-12-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation
WO1999025321A1 (en) * 1997-11-17 1999-05-27 Smithkline Beecham Corporation High drug load immediate and modified release oral dosage formulations and processes for their manufacture
DE102006027794A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antihypertonie-Kombinationswafer
GB2460915A (en) * 2008-06-16 2009-12-23 Biovascular Inc Controlled release compositions for use in reducing circulating levels of platelets
WO2010075347A2 (en) * 2008-12-23 2010-07-01 Takeda Pharmaceutical Company Limited Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone

Also Published As

Publication number Publication date
PL2428202T3 (pl) 2015-12-31
ES2547138T3 (es) 2015-10-02
EP2428202A2 (en) 2012-03-14
EP2428202B1 (en) 2015-07-01
EP2428202A3 (en) 2012-04-25

Similar Documents

Publication Publication Date Title
CY1119245T1 (el) Φαρμακευτικη συνθεση καρβετοκινης
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
CY1118093T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt
EA201170832A1 (ru) Пуриновые соединения
GEP20227397B (en) Inhibitors of influenza viruses replication
EA201100503A1 (ru) Глюкозидные производные и их применения
UA111770C2 (uk) Інгібітори бромдомену
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
MX361618B (es) Formulaciones farmacéuticas que comprenden derivados de nitrocatecol y métodos para hacer las mismas.
MX340360B (es) Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas.
CY1123382T1 (el) Απο του στοματος και ενεσιμα και σκευασματα ενωσεων τετρακυκλινης
MX2013004162A (es) Composiciones farmaceuticas que contienen un inhibidor de dgat1.
PH12015501783B1 (en) Pharmaceutical compositions for the treatment of helicobacter pylori
EA201270728A1 (ru) Пуриновые соединения
IN2012DN04868A (tr)
TR200907554A1 (tr) Oral yolla dağılan pramıpexole bileşimleri.
EA201290229A1 (ru) Производные спиролактама и их применение
GEP20156244B (en) New tertiary 8-hydroxyquinoline-7- carboxamide derivatives and usage thereof
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
TR200903014A1 (tr) Oral yolla dağılan dimebolin bileşimleri.
MX2012007426A (es) Derivados de amino-heteroarilo como bloqueadores de los canales activados por la hiperpolarizacion, controlados por nucleotidos ciclicos.
ATE546448T1 (de) Urotensin-ii-rezeptorantagonisten
TR201007508A1 (tr) Oral yolla dağılan bileşimler
TR200903548A1 (tr) Oral yolla dağılan emoksipin bileşimleri